Sulzermedica takes over German cardio business
This article was originally published in Clinica
Sulzermedica, the medical device business of Swiss engineering company Sulzer, will expand its cardiovascular know-how with the acquisition of German company Osypka and its Florida-based US subsidiary, Oscor Medical. The deal, for an undisclosed amount, will add technology in several cardiovascular areas including pacemaker leads, high-frequency cardiac ablation, catheters and external pacemakers, says Andre Buchel, head of Sulzermedica. Dr Peter Osypka will join Sulzermedica, concentrating on R&D.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.